Ryo Mizoguchi, Ph.D.

Head of Pharmaceutical Developability
Astellas Pharma Inc., Japan

Poster(s):

• (T1030-10-59) Unexpected Nucleation of Amorphous Terfenadine at a Much Lower Temperature than the Glass Transition Temperature and Its Impact on Dissolution Behavior and Physical Stability
  Tuesday, October 22, 2024

  10:30 AM – 11:30 AM MT